Filter
150
Filtered Results: 150
Text search:
Leishmaniasis
Cutánea
Featured
Recommendations
19
New Publications
27
Language
Document type
No document type
49
Studies & Reports
32
Guidelines
25
Strategic & Response Plan
10
Resource Platforms
9
Videos
9
Manuals
6
Fact sheets
5
Infographics
3
Training Material
2
Countries / Regions
Global
32
Latin America and the Carribbean
10
Ethiopia
9
India
6
Kenya
5
Africa
5
Nepal
4
Syria
4
Sudan
4
Brazil
4
Somalia
3
Iraq
3
Jordan
3
Lebanon
3
Middle East and North Africa
3
Saudi Arabia
2
Uganda
2
Pakistan
2
South Sudan
2
Turkey
2
Bangladesh
2
Colombia
2
South–East Asia Region
2
Western and Central Europe
2
Paraguay
2
Iran
2
Morocco
1
Afghanistan
1
Germany
1
Egypt
1
Tanzania
1
Cambodia
1
China
1
Malawi
1
North Macedonia
1
Bolivia
1
Greece
1
Libya
1
Myanmar / Burma
1
Yemen
1
East and Southern Africa
1
Asia
1
Venezuela
1
Eastern Europe
1
Palestine
1
Albania
1
Djibouti
1
Qatar
1
Georgia
1
Tunisia
1
Authors & Publishers
Publication Years
Category
Countries
35
Clinical Guidelines
33
Public Health
19
Key Resources
4
Women & Child Health
3
Pharmacy & Technologies
2
Capacity Building
1
Toolboxes
NTDs
77
HIV
8
Planetary Health
5
Caregiver
3
Refugee
2
Zika
2
Global Health Education
2
NCDs
2
Ebola
1
Conflict
1
Rapid Response
1
COVID-19
1
Pharmacy
1
This publication represents a key step forward in translating Control of the leishmaniases (WHO Technical Report Series, No. 949) into a more practical tool for health personnel directly involved in the case management of ...ous leishmaniasis. With this manual, countries will have, for the first time, standardized diagnosis and treatment protocols, case definitions and indicators to enable them to easily track progress on cutaneous leishmaniasis case management across the Region. It will provide support to professionals in charge of cutaneous leishmaniasis, in order to alleviate the suffering of affected populations from this appalling disfiguring and stigmatizing neglected tropical disease.
Cutaneous leishmaniasis (CL) is a neglected infectious endemic disease that is transmitted through the bite of a vector insect (sandfly) of the Lutzomyia genus,typical of rural geographical territor...
Leishmaniasis is a complex vector-borne disease involving in its transmission several species of protozoan parasites called Leishmania, a wide variety of animal reservoirs and phlebotomine sandflies vectors. ...ous Leishmaniasis (CL) is the most common form of the disease, and its clinical manifestations vary from few papules to multiple ulcers affecting the skin but also the mucous membranes, leaving permanent scars and serious disability. It is a disfiguring and stigmatizing disease that often has a devastating psychosocial and economic impact on the affected resources limited communities.
Cutaneous leishmaniasis (CL) is a parasitic disease caused by infection with a vector-borne protozoan parasite of the genus Leishmania spp. The parasite is transmitted by the bite of an infected phl...
Cutaneous leishmaniasis is a painful disease that exerts a serious toll on societies around the world that are afflicted by it. Although not life-threatening, the skin ulcers and scars it causes can...
Cutaneous Leishmaniasis (CL) is a painful disease that exerts a serious toll on societies around the world that are afflicted by it. Although not life-threatening, the skin ulcers and scars it cause...
Leishmaniasis is still considered to be a global health problem, which spreads in most countries in the world. Leishmania is an intracellular obligate protistan parasite that causes different clinical symptoms in infected humans and other animals. T...
Leishmaniasis is among the most neglected diseases. The most common form is cutaneous leishmaniasis that forms lesions on the skin.
The only trea...
We reviewed the evidence on community-based interventions for the prevention and control of cutaneous leishmaniasis (CL). Community initiatives tailored towards awareness and mobilisation are regard...
Localized cutaneous leishmaniasis and its evolving forms (diffuse cutaneous leishmaniasis, mucos...
Leishmaniasis is a vector-borne tropical/subtropical disease caused by an intracellular parasite transmitted to humans by sand fly bite. It is endemic in Asia, Africa, the Americas, and the Mediterranean region. Worldwide reports include 1.5–2 mil...
There are 3 main forms of leishmaniases: visceral (the most serious form because it is almost always fatal without treatment), cutaneous (the most common, usually causing skin ulcers), and mucocutan...
We developed an integrated vector surveillance (IVS) proposal for cutaneous leishmaniasis (CL) and visceral leishmaniasis (VL) in the Americas, bas...
The leishmaniases are a group of diseases caused by Leishmania spp., which occur in cutaneous, mucocutaneous and visceral forms. They are neglected tropical diseases (NTDs), which disproportionately...
The term leishmaniasis encompasses multiple clinical syndromes, including the cutaneous, mucosal, and visceral forms, which result from infection of macrophages in the dermis, in the naso-orpharynge...
La leishmaniasis es un problema creciente de salud pública en el contextomundial. En Colombia, la situación es de alarma debido al incremento de casos de leishmaniasis ... que se viene registrando desde 2003 y el cambio en el patrón epidemiológico dado por la aparición de nuevos focos, el proceso cre-ciente de domiciliación y urbanización del ciclo de transmisión.
Website last accessed on 04.06.2023
Bites of infected female sand flies causes the disease. The visceral form attacks internal organs; the cutaneous form causes facial ulcers, disfiguring scars and disability. #BeatNTDs
2nd edition. These guidelines include several notable changes from the first edition. For cutaneous leishmaniasis, ketoconazole has been removed from the list of treatment options; the number of Lei...
Leishmaniasis is a parasitic disease that is found in parts of the tropics, subtropics, and southern Europe. Leishmaniasis is caused by infection with Leishmania parasites, which are spread by the b...
In 2007, the Sixtieth World Health Assembly adopted resolution WHA60.13 on control of leishmaniasis, urging Member States, among other actions: to strengthen prevention, active detection and treatment of cases of both ...ous and visceral leishmaniasis in order to decrease the disease burden; and to strengthen the capacity of peripheral health centres to deliver primary and secondary care, so that they provide appropriate affordable diagnosis and treatment and act as sentinel surveillance sites.
